SCHEMBL27405111

SCHEMBL27405111

CC(C)c1cccc(N2CCCCC2(C)C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.41
DRD3 P35462 1/20 0.41
KCNH2 Q12809 1/20 0.41
NOTUM Q6P988 2/20 0.40
ESR1 P03372 2/20 0.38
ESR2 Q92731 1/20 0.38
HPGD P15428 2/20 0.37
RXRA P19793 6/20 0.36
GRIN1 Q05586 6/20 0.36
GRIN2B Q13224 6/20 0.36
LPAR5 Q9H1C0 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
CTSK P43235 1/20 0.34
ADAM10 O14672 1/20 0.33
AR P10275 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MDM4 O15151 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27720444 0.78 ALDH1A1 (0.53) DRD2DRD3ALDH1A1TP53CYP3A4
SCHEMBL27406469 0.78 NOTUM (0.39) DRD2DRD3KCNH2NOTUMESR1
SCHEMBL26607916 0.77 AR (0.43) DRD2DRD3KCNH2GRIN1GRIN2B
SCHEMBL14349225 0.75 NOTUM (0.54) DRD2DRD3KCNH2NOTUMHPGD
SCHEMBL3534359 0.75 NOTUM (0.54) DRD2DRD3KCNH2NOTUMHPGD
SCHEMBL4547919 0.74 NOTUM (0.52) NOTUMHPGDLPAR5HRH3KDM4E
SCHEMBL27405104 0.73 NOTUM (0.49) DRD2DRD3KCNH2NOTUMHPGD
SCHEMBL19701949 0.72 PIK3CD (0.47) NOTUMESR1HPGDADAM10ALDH1A1
SCHEMBL19701973 0.72 PIK3CD (0.39) DRD2DRD3KCNH2NOTUMESR1
SCHEMBL27405147 0.72 NOTUM (0.48) NOTUMHPGDHRH3ADAM10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240208968-A1 ALPHA V BETA 6 AND ALPHA V BETA 1 INTEGRIN INHIBITORS AND USES THEREOF DICE MOLECULES SV, INC. 2024-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240208968-A1 ALPHA V BETA 6 AND ALPHA V BETA 1 INTEGRIN INHIBITORS AND USES THEREOF ITGB1, ITGA1, ITGAV DRD2 2698/4885DRD3 3031/4885KCNH2 1199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.